GISSI-AF Investigators | Valsartan for prevention of recurrent atrial fibrillation.
New Engl J Med 2009. 360(16) : 1606 - 1617 |
Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G, on behalf of GISSI-AF Investigators | Rationale and design of the GISSI-atrial fibrillation trial: randomized, prospective, multicenter study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
J Cardiovasc Med 2006. 7 : 29 - 38 | |
